Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Gramon, officially known as Gramon Millet, is a leading Argentine pharmaceutical company specializing in the development and commercialization of over-the-counter (OTC) medicines and dietary supplements. As a key subsidiary of the Roemmers Group, the company holds a dominant position in the Latin American consumer healthcare market with a portfolio of iconic regional brands. Gramon's product line covers diverse therapeutic areas including respiratory health, pain management, dermatology, and nutrition. The company operates advanced manufacturing facilities in Argentina, adhering to high quality standards to serve the primary care needs of millions of patients. Through continuous innovation in galenic formulations, Gramon remains a household name for wellness and self-care solutions in the Southern Cone.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Gramon.